Category News

Sanofi and Novavax Forge Co-Exclusive Licensing Deal to Co-Market COVID-19 Vaccine and Innovate Flu-COVID-19 Combination Vaccines

Sanofi, in its pursuit of a robust vaccine portfolio, has forged a co-exclusive licensing agreement with Novavax, a biotech firm headquartered in Maryland, USA. The terms of this agreement encompass several key elements: Sanofi gains a co-exclusive license to globally…

Read MoreSanofi and Novavax Forge Co-Exclusive Licensing Deal to Co-Market COVID-19 Vaccine and Innovate Flu-COVID-19 Combination Vaccines

Partnership Announcement: New Malaria Prevention Drug Collaboration with Nagasaki University, National Institute of Infectious Diseases, and MMV, Backed by GHIT Fund

Shionogi, in collaboration with Nagasaki University (Administrative Office: Nagasaki; President: Takeshi Nagayasu, M.D., Ph.D.), the National Institute of Infectious Diseases (Head Office: Shinjuku-ku, Tokyo; Director: Takashi Wakita), and the non-profit research and development organization Medicines for Malaria Venture (MMV), has…

Read MorePartnership Announcement: New Malaria Prevention Drug Collaboration with Nagasaki University, National Institute of Infectious Diseases, and MMV, Backed by GHIT Fund

Kindeva Drug Delivery Expands Manufacturing Capabilities for Eco-Friendly Inhalers at UK Facility

Kindeva Drug Delivery, a prominent figure in the realm of drug-device combination products, has unveiled its plans to bolster its manufacturing capabilities with a second production line for pressurized metered-dose inhaler (pMDI) products at its facility in Loughborough, U.K. This…

Read MoreKindeva Drug Delivery Expands Manufacturing Capabilities for Eco-Friendly Inhalers at UK Facility

Exploring New Frontiers in Neuroscience with GE HealthCare’s SIGNA MAGNUS

GE HealthCare (Nasdaq: GEHC) has introduced SIGNA MAGNUS, a head-only magnetic resonance (MR) scanner awaiting FDA 510(k) approval. This cutting-edge technology aims to revolutionize neuroscience research, addressing the limitations of conventional whole-body MR systems. Despite significant advancements, neuroscience, particularly in…

Read MoreExploring New Frontiers in Neuroscience with GE HealthCare’s SIGNA MAGNUS

Merck Presents Cutting-Edge Pharma and Electronic Materials Production to Robert Habeck 

CVS Health Corporation (NYSE: CVS) unveiled its financial performance for the first quarter ending March 31, 2024, showcasing robust revenue growth alongside strategic adjustments to its annual guidance. First Quarter Highlights: 2024 Full-Year Guidance Revisions: CEO Commentary: Karen S. Lynch,…

Read MoreMerck Presents Cutting-Edge Pharma and Electronic Materials Production to Robert Habeck 

AbbVie Bolsters Dedication to Science and Innovation: Allocates €150 Million for State-of-the-Art Research Hub in Germany

AbbVie Initiates Construction of State-of-the-Art Research Hub, “LUnA,” in Germany with €150 Million Investment AbbVie has commenced the construction of its new central research building, dubbed “LUnA” (LUdwighafens neue Arbeitswelt), solidifying its commitment with approximately €150 million investment in its…

Read MoreAbbVie Bolsters Dedication to Science and Innovation: Allocates €150 Million for State-of-the-Art Research Hub in Germany

Bio-Techne and NovoMol-DX Unveil Point-of-Care Ocular Biomarker Test

Bio-Techne Corporation (NASDAQ: TECH) and Novomol-Dx, a pioneering molecular diagnostics firm, proudly introduce the Bio-Marker Pathfinder (BMP), a groundbreaking ocular biomarker kit designed for point-of-care application. Novomol-Dx specializes in commercializing tests for diagnosing and treating ophthalmic diseases, leveraging biomarkers discovered…

Read MoreBio-Techne and NovoMol-DX Unveil Point-of-Care Ocular Biomarker Test